On 7/30/24, Neogenomics Inc (NASDAQ: NEO) stock enjoyed a major increase of 18.0%, closing at $17.27. Moreover, this advance was accompanied by exceptionally high trading volume at 493% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 16.7% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, NEO is expected to continue to be Value Creation neutral.
Neogenomics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Neogenomics has a slightly negative Power Rating of 35 and a poor Appreciation Score of 26, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment